{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:38:00Z","timestamp":1792856280430,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:00:00Z","timestamp":1792800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:00:00Z","timestamp":1792800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05990-7","type":"journal-article","created":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:16:27Z","timestamp":1792808187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rosmarinic acid combined with cisplatin induces proliferation inhibition of hepatocellular carcinoma"],"prefix":"10.1007","author":[{"given":"Dulin","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Kang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,24]]},"reference":[{"key":"5990_CR1","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.31557\/apjcp.2021.22.5.1623","volume":"22","author":"Y An","year":"2021","unstructured":"An Y et al (2021) Rosmarinic acid induces proliferation suppression of hepatoma cells associated with NF-\u03baB signaling pathway. Asian Pac J Cancer Prev 22:1623\u20131632. https:\/\/doi.org\/10.31557\/apjcp.2021.22.5.1623","journal-title":"Asian Pac J Cancer Prev"},{"key":"5990_CR2","doi-asserted-by":"publisher","unstructured":"Chen Y, Ding D, Tang X, Ma R, Zhou JK (2025) RNA modifications in health and disease: from mechanistic insights to therapeutic applications. Precis Clin Med 8:pbaf035. https:\/\/doi.org\/10.1093\/pcmedi\/pbaf035","DOI":"10.1093\/pcmedi\/pbaf035"},{"key":"5990_CR3","doi-asserted-by":"publisher","unstructured":"Czerwi\u0144ska K, Radziejewska I (2024) Rosmarinic acid: a potential therapeutic agent in gastrointestinal cancer management-a review. Int J Mol Sci 25. https:\/\/doi.org\/10.3390\/ijms252111704","DOI":"10.3390\/ijms252111704"},{"key":"5990_CR4","doi-asserted-by":"publisher","unstructured":"Ding W et al (2026) Biologically explicable multimodal model predicting local tumor progression and tumor invasiveness of hepatocellular carcinoma. Hepatology (Baltimore, Md.). https:\/\/doi.org\/10.1097\/hep.0000000000001678","DOI":"10.1097\/hep.0000000000001678"},{"key":"5990_CR5","doi-asserted-by":"publisher","unstructured":"do Nascimento RF et al (2020) Rosmarinic acid prevents gastric ulcers via sulfhydryl groups reinforcement, antioxidant and immunomodulatory effects. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 393:2265\u20132278. https:\/\/doi.org\/10.1007\/s00210-020-01894-2","DOI":"10.1007\/s00210-020-01894-2"},{"key":"5990_CR6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","volume":"12","author":"D Du","year":"2022","unstructured":"Du D et al (2022) Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm Sin B 12:558\u2013580. https:\/\/doi.org\/10.1016\/j.apsb.2021.09.019","journal-title":"Acta Pharm Sin B"},{"key":"5990_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.joim.2024.11.003","volume":"23","author":"CY Feng","year":"2025","unstructured":"Feng CY et al (2025) Resveratrol promotes mitophagy via the MALAT1\/miR-143-3p\/RRM2 axis and suppresses cancer progression in hepatocellular carcinoma. J Integr Med 23:79\u201392. https:\/\/doi.org\/10.1016\/j.joim.2024.11.003","journal-title":"J Integr Med"},{"key":"5990_CR8","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359-386. https:\/\/doi.org\/10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"key":"5990_CR9","doi-asserted-by":"publisher","unstructured":"Foglia B, Turato C, Cannito S (2023) Hepatocellular carcinoma: latest research in pathogenesis, detection and treatment. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms241512224","DOI":"10.3390\/ijms241512224"},{"key":"5990_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cld.2022.08.004","volume":"27","author":"P Ganesan","year":"2023","unstructured":"Ganesan P, Kulik LM (2023) Hepatocellular carcinoma: new developments. Clin Liver Dis 27:85\u2013102. https:\/\/doi.org\/10.1016\/j.cld.2022.08.004","journal-title":"Clin Liver Dis"},{"key":"5990_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ppl.2026.07.003","volume":"34","author":"X Geng","year":"2026","unstructured":"Geng X, Feng B, Huang X, Wang W, Hu X (2026) Ubiquitination in hepatocellular carcinoma: mechanisms and therapeutic opportunities. Protein Pept Lett 34:1\u20134. https:\/\/doi.org\/10.1016\/j.ppl.2026.07.003","journal-title":"Protein Pept Lett"},{"key":"5990_CR12","doi-asserted-by":"publisher","unstructured":"Girgenti A et al (2025) Mitochondria-targeted Rosmarinic acid: its role against oxidative damage. Biomed Pharmacother 187:118114. https:\/\/doi.org\/10.1016\/j.biopha.2025.118114","DOI":"10.1016\/j.biopha.2025.118114"},{"key":"5990_CR13","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/516S1a","volume":"516","author":"L Gravitz","year":"2014","unstructured":"Gravitz L (2014) Liver cancer. Nature 516:S1. https:\/\/doi.org\/10.1038\/516S1a","journal-title":"Nature"},{"key":"5990_CR14","doi-asserted-by":"publisher","unstructured":"Guffanti F et al (2025) Onvansertib-based second-line therapies in combination with gemcitabine and carboplatin in patient-derived platinum-resistant ovarian carcinomas. Int J Mol Sci 26. https:\/\/doi.org\/10.3390\/ijms26125708","DOI":"10.3390\/ijms26125708"},{"key":"5990_CR15","doi-asserted-by":"publisher","unstructured":"Hamaya S, Oura K, Morishita A, Masaki T (2023) Cisplatin in liver cancer therapy. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms241310858","DOI":"10.3390\/ijms241310858"},{"key":"5990_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1055\/a-1301-8648","volume":"87","author":"M Hitl","year":"2021","unstructured":"Hitl M, Kladar N, Gavari\u0107 N, Bo\u017ein B (2021) Rosmarinic acid-human pharmacokinetics and health benefits. Planta Med 87:273\u2013282. https:\/\/doi.org\/10.1055\/a-1301-8648","journal-title":"Planta Med"},{"key":"5990_CR17","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s12967-025-06517-z","volume":"23","author":"Y Hong","year":"2025","unstructured":"Hong Y et al (2025) Decoding per- and polyfluoroalkyl substances (PFAS) in hepatocellular carcinoma: a multi-omics and computational toxicology approach. J Transl Med 23:504. https:\/\/doi.org\/10.1186\/s12967-025-06517-z","journal-title":"J Transl Med"},{"key":"5990_CR18","doi-asserted-by":"publisher","first-page":"5360","DOI":"10.1038\/s41467-025-60894-z","volume":"16","author":"M Huang","year":"2025","unstructured":"Huang M et al (2025) Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens. Nat Commun 16:5360. https:\/\/doi.org\/10.1038\/s41467-025-60894-z","journal-title":"Nat Commun"},{"key":"5990_CR19","doi-asserted-by":"publisher","unstructured":"Jiashuo WU, Fangqing Z, Zhuangzhuang LI, Weiyi J, Yue S (2022) Integration strategy of network pharmacology in traditional Chinese medicine: a narrative review. J Trad Chin Med Chung i tsa chih ying wen pan 42:479\u2013486. https:\/\/doi.org\/10.19852\/j.cnki.jtcm.20220408.003","DOI":"10.19852\/j.cnki.jtcm.20220408.003"},{"key":"5990_CR20","unstructured":"Jin B et al (2020) Detailed studies on the anticancer action of Rosmarinic acid in human Hep-G2 liver carcinoma cells: evaluating its effects on cellular apoptosis, caspase activation and suppression of cell migration and invasion. J B.U.ON.: Off J Balkan Union Oncol 25:1383\u20131389"},{"key":"5990_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13046-025-03463-y","volume":"44","author":"X Jin","year":"2025","unstructured":"Jin X et al (2025) SNRPB\/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming. J Exp Clin Cancer Res CR 44:211. https:\/\/doi.org\/10.1186\/s13046-025-03463-y","journal-title":"J Exp Clin Cancer Res CR"},{"key":"5990_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.21037\/jgo.2016.09.07","volume":"8","author":"DW Kim","year":"2017","unstructured":"Kim DW, Talati C, Kim R (2017) Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy. J Gastrointestin Oncol 8:256\u2013265. https:\/\/doi.org\/10.21037\/jgo.2016.09.07","journal-title":"J Gastrointestin Oncol"},{"key":"5990_CR23","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/s42003-025-08441-w","volume":"8","author":"Z Kong","year":"2025","unstructured":"Kong Z et al (2025) Exo-miR-1911-5p regulates ferroptosis to promote macrophages M2 polarization-mediated gastric cancer cisplatin resistance via MYB\/AKR1B10\/ACC. Commun Biol 8:1054. https:\/\/doi.org\/10.1038\/s42003-025-08441-w","journal-title":"Commun Biol"},{"key":"5990_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/s1875-5364(23)60429-7","volume":"21","author":"X Li","year":"2023","unstructured":"Li X et al (2023) Network pharmacology approaches for research of traditional Chinese medicines. Chin J Nat Med 21:323\u2013332. https:\/\/doi.org\/10.1016\/s1875-5364(23)60429-7","journal-title":"Chin J Nat Med"},{"key":"5990_CR25","doi-asserted-by":"publisher","unstructured":"Li J et al (2025a) Revealing Lingonberry\u2019s neuroprotective potential in Alzheimer\u2019s disease through network pharmacology and molecular docking. Int J Mol Sci 26. https:\/\/doi.org\/10.3390\/ijms26052363","DOI":"10.3390\/ijms26052363"},{"key":"5990_CR26","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1142\/s0192415x25500752","volume":"53","author":"X Li","year":"2025","unstructured":"Li X et al (2025b) Advancing traditional Chinese medicine research through network pharmacology: strategies for target identification, mechanism elucidation and innovative therapeutic applications. Am J Chin Med 53:2021\u20132042. https:\/\/doi.org\/10.1142\/s0192415x25500752","journal-title":"Am J Chin Med"},{"key":"5990_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13046-022-02315-3","volume":"41","author":"F Lin","year":"2022","unstructured":"Lin F et al (2022) Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2\/ITGB6 signaling axis in ovarian cancer. J Exp Clin Cancer Res CR 41:129. https:\/\/doi.org\/10.1186\/s13046-022-02315-3","journal-title":"J Exp Clin Cancer Res CR"},{"key":"5990_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41419-024-06671-0","volume":"15","author":"F Liu","year":"2024","unstructured":"Liu F et al (2024a) Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2. Cell Death Dis 15:279. https:\/\/doi.org\/10.1038\/s41419-024-06671-0","journal-title":"Cell Death Dis"},{"key":"5990_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41401-023-01158-8","volume":"45","author":"H Liu","year":"2024","unstructured":"Liu H et al (2024b) Rosmarinic acid in combination with ginsenoside Rg1 suppresses colon cancer metastasis via co-inhition of COX-2 and PD1\/PD-L1 signaling axis. Acta Pharmacol Sin 45:193\u2013208. https:\/\/doi.org\/10.1038\/s41401-023-01158-8","journal-title":"Acta Pharmacol Sin"},{"key":"5990_CR30","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier JA et al (2015) ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput 11:3696\u20133713. https:\/\/doi.org\/10.1021\/acs.jctc.5b00255","journal-title":"J Chem Theory Comput"},{"key":"5990_CR31","doi-asserted-by":"publisher","unstructured":"Morsing AE et al (2025) Age-associated B cells enhance tertiary lymphoid structures in the liver and promote HCC formation. Hepatol Commun 9. https:\/\/doi.org\/10.1097\/hc9.0000000000000816","DOI":"10.1097\/hc9.0000000000000816"},{"key":"5990_CR32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","volume":"43","author":"C Nogales","year":"2022","unstructured":"Nogales C et al (2022) Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol Sci 43:136\u2013150. https:\/\/doi.org\/10.1016\/j.tips.2021.11.004","journal-title":"Trends Pharmacol Sci"},{"key":"5990_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s0031-9422(02)00513-7","volume":"62","author":"M Petersen","year":"2003","unstructured":"Petersen M, Simmonds MS (2003) Rosmarinic acid. Phytochemistry 62:121\u2013125. https:\/\/doi.org\/10.1016\/s0031-9422(02)00513-7","journal-title":"Phytochemistry"},{"key":"5990_CR34","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/1747493018778713","volume":"13","author":"D Sacks","year":"2018","unstructured":"Sacks D et al (2018) Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int J Stroke 13:612\u2013632. https:\/\/doi.org\/10.1177\/1747493018778713","journal-title":"Int J Stroke"},{"key":"5990_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156060","volume":"135","author":"A \u015eengelen","year":"2024","unstructured":"\u015eengelen A, \u00d6nay-U\u00e7ar E (2024) Rosmarinic acid attenuates glioblastoma cells and spheroids\u2019 growth and EMT\/stem-like state by PTEN\/PI3K\/AKT downregulation and ERK-induced apoptosis. Phytomedicine 135:156060. https:\/\/doi.org\/10.1016\/j.phymed.2024.156060","journal-title":"Phytomedicine"},{"key":"5990_CR36","doi-asserted-by":"publisher","first-page":"115876","DOI":"10.1016\/j.jep.2022.115876","volume":"302","author":"L Shang","year":"2023","unstructured":"Shang L et al (2023) Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation. J Ethnopharmacol 302:115876. https:\/\/doi.org\/10.1016\/j.jep.2022.115876","journal-title":"J Ethnopharmacol"},{"key":"5990_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1515\/jtim-2024-0020","volume":"12","author":"Q Shi","year":"2024","unstructured":"Shi Q et al (2024) A Notch signaling pathway-related gene signature: characterizing the immune microenvironment and predicting prognosis in hepatocellular carcinoma. J Trans Int Med 12:553\u2013568. https:\/\/doi.org\/10.1515\/jtim-2024-0020","journal-title":"J Trans Int Med"},{"key":"5990_CR38","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25:1157\u20131174. https:\/\/doi.org\/10.1002\/jcc.20035","journal-title":"J Comput Chem"},{"key":"5990_CR39","doi-asserted-by":"publisher","unstructured":"Wang Y et al (2024a) Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: a network pharmacology approach. Phytomed Int J Phytother Phytopharmacol 123:155174. https:\/\/doi.org\/10.1016\/j.phymed.2023.155174","DOI":"10.1016\/j.phymed.2023.155174"},{"key":"5990_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.joim.2024.09.004","volume":"22","author":"XH Wang","year":"2024","unstructured":"Wang XH et al (2024b) Ginsenoside Rh1 regulates the immune microenvironment of hepatocellular carcinoma via the glucocorticoid receptor. J Integr Med 22:709\u2013718. https:\/\/doi.org\/10.1016\/j.joim.2024.09.004","journal-title":"J Integr Med"},{"key":"5990_CR41","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.freeradbiomed.2025.07.013","volume":"238","author":"X Wang","year":"2025","unstructured":"Wang X et al (2025) RTA-408 overcomes cisplatin-resistant lung cancer by inhibiting WWP1-mediated NCOA4 ubiquitination to induce ferritinophagy and ferroptosis. Free Radic Biol Med 238:595\u2013610. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.07.013","journal-title":"Free Radic Biol Med"},{"key":"5990_CR42","doi-asserted-by":"publisher","unstructured":"Wu Z et al (2024) Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer. Mol Med (Cambridge, Mass.) 30:166. https:\/\/doi.org\/10.1186\/s10020-024-00928-2","DOI":"10.1186\/s10020-024-00928-2"},{"key":"5990_CR43","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.2147\/ijn.s434950","volume":"19","author":"Y Xing","year":"2024","unstructured":"Xing Y, Jing R, Tang X, Jiang Z (2024) Dual-targeted zeolitic imidazolate frameworks drug delivery system reversing cisplatin resistance to treat resistant ovarian cancer. Int J Nanomedicine 19:6603\u20136618. https:\/\/doi.org\/10.2147\/ijn.s434950","journal-title":"Int J Nanomedicine"},{"key":"5990_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154600","volume":"109","author":"M Yang","year":"2023","unstructured":"Yang M et al (2023) Rosmarinic acid potentiates and detoxifies tacrine in combination for Alzheimer\u2019s disease. Phytomedicine 109:154600. https:\/\/doi.org\/10.1016\/j.phymed.2022.154600","journal-title":"Phytomedicine"},{"key":"5990_CR45","doi-asserted-by":"publisher","first-page":"88","DOI":"10.25259\/Cytojournal_273_2024","volume":"22","author":"T Yu","year":"2025","unstructured":"Yu T et al (2025) AZ-628 sensitizes donafenib in hepatocellular carcinoma by targeting tyrosine kinase pathway and ferroptosis. CytoJournal 22:88. https:\/\/doi.org\/10.25259\/Cytojournal_273_2024","journal-title":"CytoJournal"},{"key":"5990_CR46","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13046-023-02748-4","volume":"42","author":"C Zhang","year":"2023","unstructured":"Zhang C et al (2023a) Pulmonary interleukin 1 beta\/serum amyloid A3 axis promotes lung metastasis of hepatocellular carcinoma by facilitating the pre-metastatic niche formation. J Exp Clin Cancer Res CR 42:166. https:\/\/doi.org\/10.1186\/s13046-023-02748-4","journal-title":"J Exp Clin Cancer Res CR"},{"key":"5990_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1142\/s0192415x23500234","volume":"51","author":"J Zhang","year":"2023","unstructured":"Zhang J et al (2023b) Dihydroartemisinin affects STAT3\/DDA1 signaling pathway and reverses breast cancer resistance to cisplatin. Am J Chin Med 51:445\u2013459. https:\/\/doi.org\/10.1142\/s0192415x23500234","journal-title":"Am J Chin Med"},{"key":"5990_CR48","doi-asserted-by":"publisher","unstructured":"Zhang P et al (2023c) Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine. Brief Bioinform 25. https:\/\/doi.org\/10.1093\/bib\/bbad518","DOI":"10.1093\/bib\/bbad518"},{"key":"5990_CR49","doi-asserted-by":"publisher","unstructured":"Zhang D et al (2024) Based on network pharmacology and molecular docking, the active components, targets, and mechanisms of Flemingia philippinensis in improving inflammation were excavated. Nutrients 16. https:\/\/doi.org\/10.3390\/nu16121850","DOI":"10.3390\/nu16121850"},{"key":"5990_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116306","volume":"309","author":"L Zhao","year":"2023","unstructured":"Zhao L et al (2023) Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol 309:116306. https:\/\/doi.org\/10.1016\/j.jep.2023.116306","journal-title":"J Ethnopharmacol"},{"key":"5990_CR51","doi-asserted-by":"publisher","unstructured":"Zhao Z, Le J, Fu Z, Yang S, Chen Y (2025) Cancer network pharmacology: multi-network regulatory mechanisms and future directions. Med Oncol (Northwood, London, England) 42:255. https:\/\/doi.org\/10.1007\/s12032-025-02811-4","DOI":"10.1007\/s12032-025-02811-4"},{"key":"5990_CR52","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.joim.2025.09.002","volume":"23","author":"MF Zhong","year":"2025","unstructured":"Zhong MF, Luo YJ, Guo YY, Xiang S, Lin WF (2025) Jiedu Fang inhibits hypoxia-induced angiogenesis in hepatocellular carcinoma by targeting Aurora A\/STAT3\/IL-8 signaling pathway. J Integr Med 23:683\u2013693. https:\/\/doi.org\/10.1016\/j.joim.2025.09.002","journal-title":"J Integr Med"},{"key":"5990_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153861","volume":"95","author":"X Zhou","year":"2022","unstructured":"Zhou X et al (2022) Rosmarinic acid decreases the malignancy of pancreatic cancer through inhibiting Gli1 signaling. Phytomedicine 95:153861. https:\/\/doi.org\/10.1016\/j.phymed.2021.153861","journal-title":"Phytomedicine"},{"key":"5990_CR54","doi-asserted-by":"publisher","first-page":"66","DOI":"10.25259\/Cytojournal_91_2024","volume":"21","author":"L Zhou","year":"2024","unstructured":"Zhou L et al (2024) Deciphering the synergistic role of tyrosyl-tRNA synthetase 1 and yes-associated protein 1: catalysts of malignant progression in hepatocellular carcinoma. CytoJournal 21:66. https:\/\/doi.org\/10.25259\/Cytojournal_91_2024","journal-title":"CytoJournal"},{"key":"5990_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157593","volume":"149","author":"SY Zhou","year":"2025","unstructured":"Zhou SY et al (2025) Dihydromyricetin ameliorates vascular dementia by promoting angiogenesis via the VEGFR2 pathway: network pharmacology, molecular docking and experimental validation. Phytomedicine 149:157593. https:\/\/doi.org\/10.1016\/j.phymed.2025.157593","journal-title":"Phytomedicine"},{"key":"5990_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100933","volume":"68","author":"C Zhu","year":"2023","unstructured":"Zhu C et al (2023) CPSF6-mediated XBP1 3\u2032UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma. Drug Resist Updat 68:100933. https:\/\/doi.org\/10.1016\/j.drup.2023.100933","journal-title":"Drug Resist Updat"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05990-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05990-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05990-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:02:05Z","timestamp":1792854125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05990-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,24]]},"references-count":56,"alternative-id":["5990"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05990-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,24]]},"assertion":[{"value":"11 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study did not involve human participants or animal experiments. All experiments were performed using commercially available human hepatocellular carcinoma cell lines. No ethical approval was required for this study.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not involve any human participants; therefore, informed consent was not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not contain any individual-level human data, images or clinical case information; therefore, consent to publish is not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}